Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 25 of 37

Potential Harms of rhGH Treatment to Patients With CF

Reports of potential harms investigated for the CER were related to known risk factors for disease encountered by patients with CF, such as altered glucose control and CFRD, and elevated risk for cancer of the digestive system. Other harms are associated with the use of rhGH, such as injection-site reactions and liver-function effects. Reports of any adverse event were noted.